Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats

References

• RogerVLGoASLloyd-JonesDMAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeExecutive summary: heart disease and stroke statistics – 2012 update: a report from the American Heart AssociationCirculation2012125118819722215894
   PubMed Web of Science ®Google Scholar
• KwiatkowskiTGLibmanRBFrankelMEffects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupN Engl J Med1999340231781178710362821
   PubMed Web of Science ®Google Scholar
• García-BonillaLCamposMGiraltDEvidence for the efficacy of statins in animal stroke models: a meta-analysisJ Neurochem2012122223324322548274
   PubMed Web of Science ®Google Scholar
• Campos-MartorellMSalvadorNMongeMBrain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic modelJ Neurochem2014130230131224661059
   PubMedGoogle Scholar
• JonssonNAsplundKDoes pretreatment with statins improve clinical outcome after stroke? A pilot case-referent studyStroke20013251112111511340218
   PubMedGoogle Scholar
• Martí-FàbregasJGomisMArboixAFavorable outcome of ischemic stroke in patients pretreated with statinsStroke20043551117112115073403
   PubMedGoogle Scholar
• BalduiniWDe AngelisVMazzoniECiminoMSimvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injuryStroke20013292185219111546915
   PubMedGoogle Scholar
• JainMKRidkerPMAnti-inflammatory effects of statins: clinical evidence and basic mechanismsNat Rev Drug Discov200541297798716341063
   PubMed Web of Science ®Google Scholar
• WangC-YLiuP-YLiaoJKPleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends Mol Med2008141374418068482
   PubMed Web of Science ®Google Scholar
• TiwariGTiwariRSriwastawaBDrug delivery systems: an updated reviewInt J Pharm Investig201221211
   PubMedGoogle Scholar
• RomanaBBatgerMPrestidgeCAColomboGSonvicoFExpanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systemsCurr Top Med Chem20141491182119324678704
   PubMed Web of Science ®Google Scholar
• IshiiTFukutaTAgatoYNanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reducedBiochem Biophys Res Commun201343041201120523268342
   PubMedGoogle Scholar
• SahagunGMooreSAHartMNPermeability of neutral vs. anionic dextrans in cultured brain microvascular endotheliumAm J Physiol19902591 pt 2H162H1661695819
   PubMedGoogle Scholar
• García-BonillaLSostiVCamposMEffects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemiaBrain Res2011137321122021146508
   PubMed Web of Science ®Google Scholar
• Pérez-AsensioFJHurtadoOBurgueteMCInhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemiaNeurobiol Dis200518237538415686966
   PubMed Web of Science ®Google Scholar
• Banes-BerceliAKShawSMaGEffect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cellsAm J Physiol Renal Physiol20062911F116F12116449352
   PubMedGoogle Scholar
• LoweryAOnishkoHHallahanDEHanZTumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumorsJ Control Release2011722181204
   Google Scholar
• AferganEBen DavidMEpsteinHLiposomal simvastatin attenuates neointimal hyperplasia in ratsAAPS J201012218118720143196
   PubMed Web of Science ®Google Scholar
• PapagiannarosAKaleALevchenkoTSMongaytDHartnerWCTorchilinVPNear infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micellesInt J Nanomedicine2009412313119516891
   PubMed Web of Science ®Google Scholar
• ZhangJRodilaRGageEHigh-throughput salting-out assisted liquid/liquid extraction with acetonitrile for the simultaneous determination of simvastatin and simvastatin acid in human plasma with liquid chromatographyAnal Chim Acta2010661216717220113731
   PubMed Web of Science ®Google Scholar
• ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine20061329731517717971
   PubMed Web of Science ®Google Scholar
• JooSPXieWXiongXXuBZhaoHIschemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in miceNeuroscience201324314915723590905
   PubMed Web of Science ®Google Scholar
• ElbayoumiTATorchilinVPCurrent trends in liposome researchMethods Mol Biol201060512720072870
   PubMedGoogle Scholar
• SpuchCNavarroCLiposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)J Drug Deliv2011201146967922203906
   PubMedGoogle Scholar
• AggarwalPHallJBMcLelandCBDobrovolskaiaMAMcNeilSENanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdv Drug Deliv Rev200961642843719376175
   PubMed Web of Science ®Google Scholar
• KobeissyFHOttensAKZhangZNovel differential neuroproteomics analysis of traumatic brain injury in ratsMol Cell Proteomics20065101887189816801361
   PubMed Web of Science ®Google Scholar
• MoghimiSMHunterACMurrayJCLong-circulating and target-specific nanoparticles: theory to practicePharmacol Rev200153228331811356986
   PubMed Web of Science ®Google Scholar
• OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• GessnerALieskeAPaulkeBMüllerRInfluence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresisEur J Pharm Biopharm200254216517012191688
   PubMed Web of Science ®Google Scholar
• Hernández-CasellesTVillalaínJGómez-FernándezJCInfluence of liposome charge and composition on their interaction with human blood serum proteinsMol Cell Biochem199312021191268487752
   PubMed Web of Science ®Google Scholar
• WeissLZeigelRJungOSBrossIDBinding of positively charged particles to glutaraldehyde-fixed human erythrocytesExp Cell Res197270157644109352
   PubMedGoogle Scholar
• Swaroop KumarKJyothiTNagendarSDevipriyaSVijaya KumarGSudhakar BabuAMStability of liposomesPak J Pharm Sci1995826979
   Google Scholar
• KuroiwaTTingPMartinezHKlatzoIThe biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusionActa Neuropathol19856821221293907257
   PubMed Web of Science ®Google Scholar
• BelayevLBustoRZhaoWGinsbergMDQuantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in ratsBrain Res19967391–288968955928
   PubMed Web of Science ®Google Scholar
• YuanFLeunigMHuangSKBerkDAPapahadjopoulosDJainRKMicrovascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograftCancer Res19945413335233568012948
   PubMed Web of Science ®Google Scholar
• SchroederATurjemanKSchroederJELeibergallMBarenholzYUsing liposomes to target infection and inflammation induced by foreign body injuries or medical implantsExpert Opin Drug Deliv20107101175118920858166
   PubMed Web of Science ®Google Scholar
• LuWAdsorptive-mediated brain delivery systemsCurr Pharm Biotechnol201213122340234823016640
   PubMed Web of Science ®Google Scholar
• RoserMFischerDKisselTSurface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in ratsEur J Pharm Biopharm19984632552639885296
   PubMed Web of Science ®Google Scholar
• CavalettiGCassettiACantaACationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitisMol Pharm2009651363137019281192
   PubMedGoogle Scholar
• ErnstingMJMurakamiMRoyALiS-DFactors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesJ Control Release2013172378279424075927
   PubMed Web of Science ®Google Scholar
• VuleticSRiekseRGMarcovinaSMPeskindERHazzardWRAlbersJJStatins of different brain penetrability differentially affect CSF PLTP activityDement Geriatr Cogn Disord2006225–639239816960448
   PubMedGoogle Scholar
• SahekiATerasakiTTamaiITsujiAIn vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitorsPharm Res19941123053118165193
   PubMed Web of Science ®Google Scholar
• MisraAGaneshSShahiwalaAShahSPDrug delivery to the central nervous system: a reviewJ Pharm Pharm Sci20036225227312935438
   PubMed Web of Science ®Google Scholar
• BellostaSPaolettiRCorsiniASafety of statins: focus on clinical pharmacokinetics and drug interactionsCirculation200410923 suppl 1III50III5715198967
   PubMed Web of Science ®Google Scholar
• VickersSDuncanCAChenIWRosegayADugganDEMetabolic disposition studies on simvastatin, a cholesterol-lowering prodrugDrug Metab Dispos19901821381451971563
   PubMed Web of Science ®Google Scholar
• MauroVFClinical pharmacokinetics and practical applications of simvastatinClin Pharmacokinet19932431952028343198
   PubMed Web of Science ®Google Scholar
• LippertJBroschMvon KampenOA mechanistic, model-based approach to safety assessment in clinical developmentCPT Pharmacometrics Syst Pharmacol20121e1323835795
   PubMedGoogle Scholar
• FujinoHSaitoTTsunenariYKojimaJSakaedaTMetabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitorsXenobiotica20043411–1296197115801541
   PubMed Web of Science ®Google Scholar
• SkottheimIBGedde-DahlAHejazifarSHoelKAsbergAStatin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitroEur J Pharm Sci2008334–531732518294823
   PubMed Web of Science ®Google Scholar